TMEM106B, but not TMEM100, is significantly upregulated in coronary arteries from coronary artery disease (CAD) patients and correlated with downregulation of ANRIL.
A, Relative expression levels of ANRIL as determined by quantitative reverse transcription‐polymerase chain reaction from coronary artery tissues from CAD patients and the age‐matched non‐CAD individuals (n=6 tissues or study subjects/group). B, Relative expression levels of TMEM106B as determined by quantitative reverse transcription‐polymerase chain reaction from coronary artery tissues from CAD patients and the age‐matched non‐CAD individuals (n=6 tissues or study subjects/group). C, Relative expression levels of TMEM100 as determined by qRT‐PCR from coronary artery tissues from CAD patients and the age‐matched non‐CAD individuals (n=6 tissues or study subjects/group). Statistical analysis was performed using unpaired, 2‐tailed Student t tests.